From
http://files.shareholder.com/downloads/ABEA-474G59/4194058620x0xS1564590-17-1314/1476170/filing.pdf
The Company has also engaged a financial advisory firm to further assist with fundraising efforts. -at the same time- the company is restricted by lender as to who it can issue shares to until 30 April 17.
the Company has been evaluating the prospects of its non-wearable injector customer programs and attempting to negotiate terminations of certain non-wearable injector customer contracts- Teneo Touch gone?
The headquarters has a lien on it but may nett around $15 mil if sold.
Amgen could advance the Jan 18 $15 mil early.
Sanofi could buy in
Chapter 7 could result but I believe an administrator would be appointed and assets sold off.
Who ends up with those assets I do not know.
Chapter 11 seems more likely with Orbimed funding but the company could put to the courts and restructure all contracts and I am thinking Sanofi won't come out of this too well.
I believe this will consume the courts for years if SH are shafted.
All IMO
- Forums
- ASX - By Stock
- UNS
- Where are we at
Where are we at, page-8
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
KAI
Pilbara Minerals buys land off Kairos part of its York gold project for $20M – and a 2% royalty on any PLS gold sales
STX
Strike hands $48.5M contract to Clarke Energy to produce 20x 4.5MW gas engines for Sth Erregulla